275 related articles for article (PubMed ID: 24367678)
21. Paradoxical and Unmasking HIV Immune Reconstitution Inflammation Syndrome in Antiretroviral-Naïve Pregnant Women: A Prospective Cohort Study.
Muthuka JK; Nyamai EM; Oluoch K; Maibvise C; Nabaweesi R
Cureus; 2024 Jan; 16(1):e52989. PubMed ID: 38406047
[TBL] [Abstract][Full Text] [Related]
22. Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients.
van Bilsen WPH; van den Berg CHSB; Rijnders BJA; Brinkman K; Mulder JW; Gelinck LBS; Hoepelman AIM; Wit FWNM; van de Beek D; Prins JM
AIDS; 2017 Jun; 31(10):1415-1424. PubMed ID: 28375874
[TBL] [Abstract][Full Text] [Related]
23. The immune reconstitution inflammatory syndrome with tuberculosis: a common problem in Ethiopian HIV-infected patients beginning antiretroviral therapy.
Ali K; Klotz SA
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):198-202. PubMed ID: 21521804
[TBL] [Abstract][Full Text] [Related]
24. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India.
Kumarasamy N; Venkatesh KK; Vignesh R; Devaleenal B; Poongulali S; Yepthomi T; Flanigan TP; Benson C; Mayer KH
J Int Assoc Provid AIDS Care; 2013; 12(1):28-31. PubMed ID: 23011868
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.
Achenbach CJ; Harrington RD; Dhanireddy S; Crane HM; Casper C; Kitahata MM
Clin Infect Dis; 2012 Feb; 54(3):424-33. PubMed ID: 22095568
[TBL] [Abstract][Full Text] [Related]
27. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.
Müller M; Wandel S; Colebunders R; Attia S; Furrer H; Egger M;
Lancet Infect Dis; 2010 Apr; 10(4):251-61. PubMed ID: 20334848
[TBL] [Abstract][Full Text] [Related]
28. Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.
Letang E; Miró JM; Nhampossa T; Ayala E; Gascon J; Menéndez C; Alonso PL; Naniche D
PLoS One; 2011 Feb; 6(2):e16946. PubMed ID: 21386993
[TBL] [Abstract][Full Text] [Related]
29. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.
Luetkemeyer AF; Kendall MA; Nyirenda M; Wu X; Ive P; Benson CA; Andersen JW; Swindells S; Sanne IM; Havlir DV; Kumwenda J;
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):423-8. PubMed ID: 24226057
[TBL] [Abstract][Full Text] [Related]
30. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
Haddow LJ; Moosa MY; Mosam A; Moodley P; Parboosing R; Easterbrook PJ
PLoS One; 2012; 7(11):e40623. PubMed ID: 23152745
[TBL] [Abstract][Full Text] [Related]
31. The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children.
Orikiiriza J; Bakeera-Kitaka S; Musiime V; Mworozi EA; Mugyenyi P; Boulware DR
AIDS; 2010 Aug; 24(13):2009-17. PubMed ID: 20616700
[TBL] [Abstract][Full Text] [Related]
32. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
[TBL] [Abstract][Full Text] [Related]
33. Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review.
Manzardo C; Guardo AC; Letang E; Plana M; Gatell JM; Miro JM
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):751-67. PubMed ID: 25860288
[TBL] [Abstract][Full Text] [Related]
34. Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia.
Sereti I; Sheikh V; Shaffer D; Phanuphak N; Gabriel E; Wang J; Nason MC; Roby G; Ngeno H; Kirui F; Pau A; Mican JM; Rupert A; Bishop R; Agan B; Chomchey N; Teeratakulpisarn N; Tansuphaswadikul S; Langat D; Kosgei J; French M; Ananworanich J; Sawe F
Clin Infect Dis; 2020 Jul; 71(3):652-660. PubMed ID: 31504347
[TBL] [Abstract][Full Text] [Related]
35. Immune reconstitution inflammatory syndrome: incidence and implications for mortality.
Novak RM; Richardson JT; Buchacz K; Chmiel JS; Durham MD; Palella FJ; Wendrow A; Wood K; Young B; Brooks JT;
AIDS; 2012 Mar; 26(6):721-30. PubMed ID: 22233655
[TBL] [Abstract][Full Text] [Related]
36. Association of CD4 T cell count and optimal timing of antiretroviral therapy initiation with immune reconstitution inflammatory syndrome and all-cause mortality for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis.
Li L; Li J; Chai C; Liu T; Li P; Qu M; Zhao H
Int J Clin Exp Pathol; 2021; 14(6):670-679. PubMed ID: 34239668
[TBL] [Abstract][Full Text] [Related]
37. Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy.
Huyst V; Lynen L; Bottieau E; Zolfo M; Kestens L; Colebunders R
Acta Clin Belg; 2007; 62(2):126-9. PubMed ID: 17547295
[TBL] [Abstract][Full Text] [Related]
38. Treatment outcomes after early initiation of antiretroviral therapy for human immunodeficiency virus-associated tuberculosis.
Chan CK; Wong KH; Leung CC; Tam CM; Chan KC; Pang KW; Chan WK; Mak IK
Hong Kong Med J; 2013 Dec; 19(6):474-83. PubMed ID: 23926173
[TBL] [Abstract][Full Text] [Related]
39. Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy.
Gkentzi D; Tebruegge M; Tudor-Williams G; Walters S; Lyall H; Sharland M; Doerholt K
Pediatr Infect Dis J; 2014 Sep; 33(9):953-8. PubMed ID: 24618936
[TBL] [Abstract][Full Text] [Related]
40. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
Bonnet M; Bhatt N; Baudin E; Silva C; Michon C; Taburet AM; Ciaffi L; Sobry A; Bastos R; Nunes E; Rouzioux C; Jani I; Calmy A;
Lancet Infect Dis; 2013 Apr; 13(4):303-12. PubMed ID: 23433590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
